Premature ovarian insufficiency (POI)—also known as premature ovarian failure—is a condition in which the ovaries stop functioning normally before the age of 40, leading to a premature drop in estrogen levels and the cessation of regular menstrual cycles. The main causes include chromosomal abnormalities (Turner syndrome, FMR1 gene premutation), autoimmune diseases, gonadotoxic treatments such as chemotherapy or pelvic radiation therapy, and environmental factors. In 50 to 90% of cases, no cause is identified.
The diagnosis is based on a blood hormone panel: elevated FSH (greater than 25 IU/L) on two separate occasions at least one month apart, combined with low estradiol levels, confirms ovarian insufficiency in a woman under 40 years of age. An anti-Müllerian hormone (AMH) test reflects the remaining ovarian reserve. A pelvic ultrasound assesses the size of the ovaries and the number of antral follicles. Genetic and immunological testing often completes the workup to determine the cause.
Treatment for POI aims to compensate for the hormonal deficiency and prevent long-term complications. Hormone replacement therapy (HRT)—estrogen and progesterone—is recommended until the age of natural menopause to protect bone health, the cardiovascular system, and brain health. For women wishing to conceive, IVF with egg donation remains the most effective option. Calcium and vitamin D3 supplementation is routinely recommended to maintain bone density.
Ovarian insufficiency profoundly affects fertility: the probability of conceiving spontaneously is low, estimated at 5 to 10 percent. Sporadic ovulation may occur, however, making pregnancy possible without treatment in rare cases. IVF with egg donation offers the best chances of conception—with success rates comparable to those of women with young donors. Fertility preservation before any gonadotoxic treatment should always be considered.
Yes. With properly managed hormone therapy and regular medical follow-up, women with POI can lead normal lives. Hormone replacement therapy (HRT) effectively alleviates symptoms—hot flashes, vaginal dryness, and sleep disturbances—and reduces cardiovascular and bone-related risks. A balanced diet rich in omega-3 fatty acids and phytoestrogens—such as soy and flaxseed—supports hormonal balance. Regular physical activity helps maintain bone mass and cardiovascular health.
POF can have a significant emotional impact: feelings of loss, anxiety, reactive depression, and grief over the loss of natural fertility are common. Since the diagnosis often occurs during a period of active life, it can be difficult to accept. Psychological support—individual therapy or support groups—is strongly recommended to help navigate these challenges. Open communication with your partner and loved ones is also a key factor in emotional recovery.
A genetic component is found in 10 to 15% of cases. FMR1 gene premutation (associated with Fragile X syndrome), certain chromosomal abnormalities, and rare genetic variants increase the risk within a family. Women with a first-degree family history of premature ovarian insufficiency should undergo genetic testing and monitoring of their ovarian reserve—ideally before planning a pregnancy—to allow for fertility preservation if necessary.
Prevention is limited when the cause is genetic or autoimmune. However, limiting exposure to endocrine disruptors, avoiding smoking, and maintaining a stable weight can help preserve ovarian reserve. Before any cancer treatment, the cryopreservation of oocytes or ovarian tissue offers a means of preserving fertility. Regular hormone monitoring at the first signs—such as irregular cycles in women under 40—facilitates early diagnosis and treatment.
